SuperworthElevance Health shares outstanding ELV
Diluted shares outstanding, averaged over each quarter, from 2008.
- Latest quarter, to Jun 30, 2026
- 217.9M
- On a year earlier
- −3.5%
- fewer shares
Elevance Health had 217.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 3.5% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 221.6M | −4% |
| FY2024 | 230.8M | −2% |
| FY2023 | 235.6M | −2% |
| FY2022 | 241.3M | −2% |
| FY2021 | 245.6M | −2% |
| FY2020 | 251.3M | −3% |
| FY2019 | 257.9M | −2% |
| FY2018 | 263.9M | +0% |
| FY2017 | 263.1M | −2% |
| FY2016 | 268.7M | +0% |
| FY2015 | 267.9M | −5% |
| FY2014 | 281.2M | −7% |
| FY2013 | 301.7M | −2% |
| FY2012 | 307.2M | −12% |
| FY2011 | 349.7M | −11% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 217.9M | −3% | |
| Q1 FY26 | 220.4M | −3% | |
| Q4 FY25 | 221.6M | −4% | |
| Q3 FY25 | 223.7M | −4% | |
| Q2 FY25 | 225.8M | −3% | |
| Q1 FY25 | 227.2M | −3% | |
| Q4 FY24 | 230.8M | −2% | |
| Q3 FY24 | 233.1M | −1% | |
| Q2 FY24 | 233.4M | −2% | |
| Q1 FY24 | 234.2M | −2% | |
| Q4 FY23 | 235.6M | −2% | |
| Q3 FY23 | 236.5M | −2% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Elevance Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.